High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm von Dunbar, Lala M, Wunderink, Richard G, Habib, Michael P, Smith, Leon G, Tennenberg, Alan M, Khashab, Mohammed M, Wiesinger, Barbara A, Xiang, Jim X, Zadeikis, Neringa, Kahn, James B

Volltext

Levofloxacin Efficacy in the Treatment of Community-Acquired Legionellosis von Yu, Victor L., Greenberg, Richard N., Zadeikis, Neringa, Stout, Janet E., Khashab, Mohammed M., Olson, William H., Tennenberg, Alan M.

Volltext

Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study von Bundrick, William, Heron, Sean P, Ray, Paul, Schiff, William M, Tennenberg, Alan M, Wiesinger, Barbara A, Wright, Pamela A, Wu, Shu-Chen, Zadeikis, Neringa, Kahn, James B

Volltext

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens von Dunbar, Lala M., Khashab, Mohammed M., Kahn, James B., Zadeikis, Neringa, Xiang, Jim X., Tennenberg, Alan M.

Volltext

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumon... von Shorr, Andrew F., Zadeikis, Neringa, Xiang, Jim X., Tennenberg, Alan M., Wes Ely, E.

Volltext

Levofloxacin for Treatment of Ventilator-Associated Pneumonia: A Subgroup Analysis from a Randomized Trial von Shorr, Andrew F., Zadeikis, Neringa, Jackson, William L., Ramage, Anthony S., Wu, Shu-Chen, Tennenberg, Alan M., Kollef, Marin H.

Volltext

Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia von Jr, Thomas M. File, Milkovich, Gary, Tennenberg, Alan M., Xiang, Jim X., Khashab, Mohammed M., Zadeikis, Neringa

Volltext

Levofloxacin 750mg daily for 5 days for Community Acquired Pneumonia: Outcomes in the Elderly von Shorr, Andrew F., Zadeikis, Neringa, Khashab, Mohammed M., Tennenberg, Alan M., Ely, E.W.

Volltext

Levofloxacin for treatment of ventilator-associated pneumonia : A subgroup analysis from a randomized trial: The Effective Use of Levofloxacin against Respiratory Infections Caused... von SHORR, Andrew F, ZADEIKIS, Neringa, JACKSON, William L, RAMAGE, Anthony S, WU, Shu-Chen, TENNENBERG, Alan M, KOLLEF, Marin H

Volltext

Impact of Co-morbid Illness and Frequent Exacerbations on the Bacteriology of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB von Tennenberg, Alan M., Walker, Karen A., Khashab, Mohammed, Fisher, Alan, Zadeikis, Neringa, Kahn, James B.

Volltext

Comparative Study of Infectious Complications of Different Types of Chronic Central Venous Access Devices von Zadeikis, Neringa

Volltext

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradig von Dunbar, Lala M., Wunderink, Richard G., Habib, Michael P., Smith, Leon G., Tennenberg, Alan M., Khashab, Mohammed M., Wiesinger, Barbara A., Xiang, Jim X., Zadeikis, Neringa, Kahn, James B.

Volltext

High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm. Commentary von DUNBAR, Lala M, WUNDERINK, Richard G, MANDELL, Lionel A, FILE, Thomas M, HABIB, Michael P, SMITH, Leon G, TENNENBERG, Alan M, KHASHAB, Mohammed M, WIESINGER, Barbara A, XIANG, Jim X, ZADEIKIS, Neringa, KAHN, James B

Volltext